Objective. To test the hypothesis that cerebrovascular responses to hypercapnia are attenuated in a non-clinical population-based cohort.
Introduction
Individuals with obstructive sleep apnea (OSA) syndrome are at increased risk for cardiovascular disease, including hypertension and stroke [1] [2] [3] ; however, the underlying mechanisms remain obscure. Putative links between OSA and stroke include oxidative stress 4 , coagulopathies [5] [6] [7] , thromboembolism associated with atrial fibrillation 8 and patent foramen ovale 9 , and carotid atherosclerosis caused by snoring-related vibration 10 . Structural abnormalities involving extracranial cerebral arteries (e.g. increased carotid intima-media thickness and augmented carotid-femoral pulse wave velocity) have been documented in patients with moderate to severe OSA [11] [12] [13] . In addition, functional responses of intracranial cerebral arteries to CO 2 , a powerful vasodilator in the cerebral circulation, are greatly attenuated [14] [15] [16] .
The clinical significance of blunted hypercapnic vasodilation is unknown; however, previous investigators have observed an association between cerebral CO 2 reactivity and endothelial function in the forearm 17 , a biomarker known to be a strong predictor of cardiovascular disease risk [18] [19] [20] . In addition, impaired vascular responsiveness to CO 2 may exacerbate breathing instability during sleep. Because hypercapnic vasodilation minimizes changes in brain PCO 2 during fluctuations in arterial PCO 2 , reductions in vascular reactivity could exaggerate the accumulation and also the washout of CO 2 from central chemoreceptors during fluctuations in ventilation. Thus, impaired vascular response to hypercapnia is a potential contributor to both the causes and the consequences of sleep disordered breathing (SDB).
Our current knowledge of the effects of SDB on cerebrovascular function is derived from clinic-based samples of individuals with relatively severe SDB. Similar impairments have not been documented across the spectrum of SDB severity, even though diminished endothelial function in the forearm has been demonstrated in epidemiologic studies 21;22 . Therefore, we sought to test the hypothesis that hypercapnic vasodilation in the cerebral circulation, an endothelium-dependent process, is blunted in individuals with SDB. Accordingly, we examined the relationship between SDB and cerebrovascular responsiveness to hypercapnia in a population-based cohort free of clinical selection biases. Some of the results of this study have been previously reported in abstract form 23 .
Methods

Subjects
Detailed sampling methods and characteristics of the Wisconsin Sleep Cohort Study have been described previously 24 . Briefly, over the past 20 years, a random sample of 1550 men and women was recruited from a sampling frame of payroll records of several Wisconsin state agencies to undergo polysomnographic examinations at four-year intervals. Four hundred twenty male and female participants of the Wisconsin Sleep Cohort Study who were scheduled to undergo follow-up evaluations during the years 2004-2008 were recruited to also participate in the present ancillary investigation of cerebrovascular function. Potential subjects were screened for current, serious medical problems via a self-reported history questionnaire that was followed up by a physical examination, if necessary. In this manner, physician clearance was obtained for all subjects prior to participation. Twenty-one potential participants were deemed not healthy enough to undergo the rebreathing test, 2 declined participation after receiving an explanation of procedures, in 7 instances there were equipment failures, and in 17 subjects we were unable to obtain an adequate Doppler signal. Characteristics of the remaining 373 subjects are shown in Table 1 . The parent study and this subprotocol were approved by the University of Wisconsin-Madison's Health Sciences Institutional Review Board. 30 to insonate the artery through the right temporal window in the majority of subjects.
In a small fraction of subjects, we used the left temporal window when an adequate signal could not be obtained on the right side. After the quality of the signal was maximized, the Doppler probe was secured using a headband device to provide a fixed angle of insonation. Heart rate was measured from the electrocardiogram. Beat-by-beat arterial pressure was measured by photoelectric plethysmography (Finapres, Ohmeda, Louisville, CO, USA We used a modified Read rebreathing test 31 to assess cerebrovascular responses to hyercapnia. A 6-liter anesthesia bag was attached by means of a 2-way valve to a mouthpiece.
Prior to initiation of the rebreathing test, this bag was filled with a volume of air equal to the subject's predicted vital capacity + 1 liter that had a gas composition of 3% CO 2 and 40% O 2 .
Predicted vital capacity was calculated using the following equations 32 :
Males: 0.052 * height (cm) -.022 * age -3.6
Females: 0.047 * height (cm) -.029 * age -2.9.
The test began with a baseline period of room air breathing through the mouthpiece with the nose occluded in which at least 4 mins of stable normoxic, normocapnic breathing were recorded. After the baseline recordings were complete, the valve was turned to allow rebreathing from the bag. The P ET CO 2 level of the first breath from the bag was noted, and rebreathing continued until P ET CO 2 reached +10 mmHg above this level. In most subjects, this level was reached within 2.5 mins. Then, the valve was opened to room air, and after the first room air breath, the mouthpiece and noseclip were removed.
Calculation of Outcome Variables
All signals were analyzed using custom-written software. Cerebral flow velocity for each cardiac cycle was determined by integrating the Doppler signal and dividing by the length of the cycle (i.e. velocity-time integral). Mean arterial pressure (MAP) was calculated as 1/3 pulse pressure + diastolic pressure. Within-breath averages were computed for velocity-time integral, heart rate, and MAP. To quantify vascular responsiveness to CO 2 , we performed breath-bybreath linear regression analysis of velocity-time integral vs. P ET CO 2 . The slope of this relationship was used to make between-subject comparisons of cerebrovascular CO 2 responsiveness (CCR; cm/sec/mmHg P ET CO 2 ). The day-to-day reliability of these measurements, assessed in 9 healthy subjects, was good (Intraclass Correlation Coefficient=0.80). Linear regression analysis was also used to determine the change, per mmHg P ET CO 2 , in secondary outcome measures of MAP, heart rate, and ventilation during rebreathing. Quantification of physiological variables associated with the rebreathing test was performed by one of two study personnel. To assess the reliability of our analysis procedures, we performed duplicate quantifications for every 15 th subject tested. This examination revealed excellent repeatability (Intraclass Correlation Coefficients >0.99).
Statistical analysis. The distributions of all variables assessed in the Cerebrovascular Reactivity
Protocol were approximately normal. We performed linear regression analyses with CCR as the primary outcome variable. The MAP, heart rate, and ventilatory responses during rebreathing were secondary outcome variables. We examined SDB severity as the independent variable, using two different representations. One was the AHI, categorized into severity levels (1: AHI < Initially, we examined unadjusted relationships. Secondarily, we adjusted for age, sex, BMI, waist to hip ratio, current smoking, alcohol use (drinks/week), and the presence of diabetes. We adjusted for these potential confounders because of their known influence on SDB and endothelial function [33] [34] [35] [36] [37] [38] . In addition, for CCR, we also examined models that included an adjustment for the increase in MAP during rebreathing. It was necessary to adjust for MAP because it is an indicator of cerebral perfusion pressure, an important determinant of cerebral blood flow 39 . Finally, we also examined two-way interactions between SDB:CCR relationships and age, sex, and excessive daytime sleepiness.
We used beta coefficients from the model and population means for the confounding variables to estimate least square means of our outcomes for the AHI severity level categories.
We used the beta coefficient to estimate the effect of log AHI and mean level of oxygen saturation. Chi-square t-tests were used to assess statistical significance and p-values less than 0.05 were considered statistically significant for main effects. For interaction terms, we used a more conservative α level of p<0.01. SAS software (Version 9.1.3, SAS Institute, Carey, NC, USA) was used for all analysis.
Results
Seventeen of 390 participants (5 men and 12 women) were excluded from analysis because of inability to obtain an adequate Doppler signal. These participants tended to have higher BMI, but did not differ from the remaining subjects in terms of AHI, presence of diabetes, or history of cardiovascular disease (data not shown).
Baseline cardiovascular and respiratory variables. Summary data for cardiovascular and respiratory variables measured prior to the rebreathing test are shown in Table 2 . Minute ventilation was somewhat elevated in patients in the highest AHI category and in CPAP users relative to other categories; however, P ET CO 2 was comparable in all groups.
Cardiovascular and respiratory variables during rebreathing. The rebreathing protocol was generally well-tolerated. We did not observe signs of hemodynamic instability in any participant.
Transient breathlessness was the most commonly reported symptom. The rebreathing test elicited, on average, increases in heart rate of 1 beat/min, MAP of 12 mmHg, and minute ventilation of 17 liters/min. Summary data for these variables and CCR are shown in Table 3 .
We observed a significant positive correlation between CCR and mean SaO 2 during sleep (Table 4 and Figure 2 We also evaluated the association between CCR and AHI (Table 5 ). When AHI category was used as a trend variable, the association was nearly significant in the unadjusted analysis (p=0.050); however, when alcohol consumption, smoking, diabetes, and waist:hip ratio were added to the model, the correlation was not significant (p=0.111). The association between CCR and AHI category was also non-significant when MAP increase during rebreathing was added to the model (p=0.179). Qualitatively similar results were found when using continuous AHI (log(AHI+1)) instead of categorical AHI: The unadjusted coefficient (SE) for CCR regressed on log(AHI+1) was -0. We observed an inverse relationship between AHI category and increase in MAP during rebreathing that was of borderline significance (p=0.079). In contrast, there was no significant relationship between AHI and change in heart rate during rebreathing (p=0.208) or hypercapnic ventilatory response (p=0.182).
Although we did not include data from current CPAP users in our statistical models, we did assess cerebrovascular reactivity in these individuals. In current CPAP users, the mean value for CCR (2.3±0.2) was lower than in individuals with AHI<5 but higher than in those with AHI>30 (Table 3) .
Discussion
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The major finding of this study is that hypercapnic vasodilation in the cerebral circulation, an exquisitely sensitive physiological mechanism responsible for minimizing changes in brain tissue PCO 2 during fluctuations in arterial CO 2 , is diminished, in graded fashion, across the continuum of mild to severe SDB. We observed a significant positive correlation between the mean level of SaO 2 during sleep and cerebrovascular CO 2 reactivity. In contrast, AHI, regardless of whether it was represented as a categorical or continuous variable, was not statistically significantly associated with cerebrovascular CO 2 reactivity. Although we cannot infer causation from our observational data, we interpret these findings as indirect evidence that nocturnal hypoxemia contributes importantly to impaired cerebrovascular function in individuals with SDB.
This conclusion is predicated on the assumption that reductions in SaO 2 during sleep were caused by SDB. Alternatively, SaO 2 may have been reduced secondary to lung disease.
However, we believe this possibility was minimized because participants with a history of lung disease and those taking medications used to treat lung disease were excluded from this analysis. Also, our assumption that the reduction in CCR we observed in participants in the lower quartiles of nocturnal SaO 2 represents impaired hypercapnic vasodilation is valid only if the rebreathing test evoked comparable increases in MAP across all subject groups. This is a reasonable assumption because there was no correlation between nocturnal SaO 2 and MAP during rebreathing and because the SaO 2 :CCR relationship was statistically significant both before and after adjustment for the increase in MAP. In contrast, the AHI:CCR relationship was confounded by between-group differences in MAP: a negative correlation of borderline significance was observed between AHI and MAP during rebreathing. Thus, it is not possible to discern whether CCR was lower in participants with higher AHI because of blunted hypercapnic vasodilation or whether CCR was lower secondary to smaller increases in cerebral perfusion pressure during rebreathing. The finding that the AHI:CCR relationship became statistically non-significant after adjustment for the increase in MAP during rebreathing points to the latter possibility. Our data are consistent in demonstrating that, across a wide spectrum of SDB, the mean level of SaO 2 during sleep better predicts the blunting of CO 2 reactivity than does the frequency of events (i.e. AHI).
In contrast to the significant negative correlation between SDB and CCR in our subjects, ventilatory responses during rebreathing did not vary according to SaO 2 or AHI category. In one previous study, enhanced ventilatory responses to CO 2 were reported in OSA patients vs.
control subjects 40 ; however, several other studies have found no between-group differences 16;41;42 . We speculate that much of the variability in ventilatory responses to CO 2 is attributable to performance of these studies during wakefulness, when non-chemoreceptor, behavioral inputs have a substantial influence on respiratory output.
The present findings in a population-based sample free of clinical selection biases are consistent with our previous observations of diminished CCR in patients with moderate-tosevere OSA 16 . The magnitude of CCR decrement in the present subjects who fell within the lowest vs. the highest quartiles of nocturnal SaO 2 values was similar to that observed in our clinic-based sample (-17 vs. -22%). Because the average CCR in CPAP users was enhanced relative to participants with untreated SDB and AHI >30, the present findings suggest that SDBrelated impairment in cerebrovascular function is reversible, at least in part, with treatment. This finding also agrees with our previous observations of patients with moderate to severe obstructive sleep apnea 16 . Nevertheless, because the average CCR in CPAP users was still somewhat diminished relative to that of participants with no SDB (AHI<5), the present data also suggest that CPAP does not provide full protection against this vascular consequence of SDB.
A potential reason is that many individuals are not fully compliant with this treatment. Patients who are considered "CPAP compliant" use the device for as few as four hours on most nights [43] [44] [45] . Thus, many of them remain exposed, for varying amounts of time, to the adverse effects of SDB and resultant intermittent hypoxemia.
The present findings also parallel two previous population-based studies that used flowmediated dilation in the forearm to assess vascular function 21;22 . All three studies found associations between vascular dysfunction and SDB severity. Consistent with the present findings, one previous study found that nocturnal SaO 2 was a more important predictor of vascular function than was AHI 21 . The other previous study observed that SDB was associated with impaired vascular function in women, but not men 22 . In the present study, the interaction between sex and SDB-associated vascular dysfunction was not statistically significant.
Interestingly, a significant positive correlation was observed between vascular reactivity and alcohol consumption in one previous report 22 . A similar correlation was not present in our study.
Mechanisms of SDB-induced impairment in cerebrovascular reactivity. Hypercapnic vasodilation
in the brain is a complex, endothelium-dependent process: nitric oxide, prostacyclin, and cytochrome P-450 metabolites have all been implicated [46] [47] [48] . Endothelium-dependent dilation in the forearm is blunted in individuals with SDB 21;49-51 . The causes of this impairment are not well understood; however, oxidative stress (i.e. imbalance between production of reactive oxygen species and anti-oxidant defenses) and inflammation are putative contributors. Both processes have been observed in patients with OSA , which suggests an important role for xanthine oxidasederived superoxide. Excess superoxide would be expected to reduce the availability of nitric oxide by combining with it to form peroxynitrite. Peroxynitrite, in turn, could further limit nitric oxide via oxidation of tetrahydrobiopterin, a critical co-factor for endothelial nitric oxide synthase 53;54 . Peroxynitrite could also limit prostacyclin production by suppression of prostacyclin synthase 55 . We speculate that the pathological processes that interfere with endothelium-dependent vasodilation in the forearm also contribute to the observed blunting of hypercapnic vasodilation in the cerebral circulation. . Also, one of our measures of SDB severity, AHI, has limited reliability, especially over a single night of observation. Nevertheless, with 373 subjects, we believe our study is adequately powered considering the known night-to-night variability 59 .
In the absence of SaO 2 measurements during wakefulness and concurrent measurements of pulmonary function, individuals with lung disease were identified based on self-reported medical history and use of medications used to treat lung disease. We recognize that this imprecise method is a limitation of our study.
Finally, in this cross-sectional study, we cannot uncover the temporal nature of the relationship between SDB and blunted CCR. On one hand, SDB could cause impairment in reactivity via intermittent hypoxemia and attendant insults to vascular structure and function. On the other hand, diminished cerebrovascular CO 2 reactivity could cause or exacerbate SDB.
Answers to these questions await longitudinal observations in population-based studies.
Clinical significance of the present findings. Several previous reports suggest that the observed impairments in CCR may be clinically relevant. In patients with essential hypertension and diabetes mellitus, impaired CCR was correlated with endothelial dysfunction in the forearm 17 , a strong predictor of cardiovascular disease risk 18;20 . Because hypercapnic vasodilation in the cerebral circulation is evoked by substances produced in endothelial cells [46] [47] [48] , we believe that CCR is a proxy measure of endothelial function and therefore may also be a predictor of cardiovascular risk. Diminished cerebrovascular responsiveness to CO 2 has been observed in patients with ischemic stroke 60 and those with multiple subcortical infarctions 61 . Therefore, this functional impairment may play a pathogenetic role in cerebrovascular disease. Further, in patients with congestive heart failure, CCR was correlated with ejection fraction, prompting the speculation that depressed cerebrovascular reactivity may be responsible for cognitive impairments in patients with severe ventricular dysfunction 62 . We have shown that CCR is reduced in patients with heart failure and central sleep apnea relative to patients with similar cardiac dysfunction but without central sleep apnea 
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